Showing results (101-110 of 132) with videos related to
Sort By:
Pageof 14
Cancer|August 27, 2015
Extent of resection and overall survival for patients with atypical and malignant meningiomaAyal A Aizer, Wenya Linda Bi, Manjinder S Kandola, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2014
Incidence and determinants of 1-month mortality after cancer-directed surgeryB A Mahal, G Inverso, A A Aizer, et al.Journal of Neuro-Oncology|February 5, 2019
Local control after brain-directed radiation in patients with cystic versus solid brain metastasesRachel H Brigell, Daniel N Cagney, Allison M Martin, et al.Clinical Genitourinary Cancer|May 28, 2014
Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancerBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.Prostate Cancer and Prostatic Diseases|July 2, 2014
The association between insurance status and prostate cancer outcomes: implications for the Affordable Care ActB A Mahal, A A Aizer, D R Ziehr, et al.Neuro-Oncology|February 5, 2019
A low percentage of metastases in deep brain and temporal lobe structuresTed K Yanagihara, J Ricardo McFaline-Figueroa, Nicholas J Giacalone, et al.Breast Cancer Research and Treatment|April 15, 2019
Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastasesDaniel N Cagney, Nayan Lamba, Sofia Montoya, et al.The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.Pharmacology & Therapeutics|October 10, 2025
Treatment strategies for leptomeningeal disease in patients with breast cancerLennard Spanehl, Thomas Grinda, Rishab Ramapriyan, et al.Journal of Neuro-Oncology|October 5, 2017
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab aloneNils D Arvold, Diana D Shi, Ayal A Aizer, et al.Pageof 14